Synthesis and antimicrobial evaluation of novel 1,3-thiazoles and unsymmetrical azines
作者:Mohamed El-Kady、Eman M. H. Abbas、Marwa S. Salem、Asmaa F. M. Kassem、Sherein I. Abd El-Moez
DOI:10.1007/s11164-015-2214-z
日期:2016.4
derivatives have been synthesized via reaction of 1-(1-(5,6-dimethoxy-2-oxobenzo[d]thiazol-3(2H)-yl)propan-2-ylidene)-4-substitutedthiosemicarbazide with different halides, namely, ethyl bromoacetate, ethyl-2-bromopropionate, phenacyl bromide, p -bromophenacyl bromide and/or substituted hydrazonoyl halides. The new compounds were evaluated as antimicrobial agents.
Novel 2-thiazolylphthalazine derivatives were efficiently synthesized underultrasoundirradiation, resulting in high yields and short reaction times after optimization of the reaction conditions. All prepared compounds were fully characterized using spectroscopic methods. They were screened for their antimicrobial activity against Gram-positive and Gram-negative bacteria as well as for antifungal
Eco-Friendly Synthesis, Characterization and Biological Evaluation of Some Novel Pyrazolines Containing Thiazole Moiety as Potential Anticancer and Antimicrobial Agents
作者:Mastoura Edrees、Sraa Melha、Amirah Saad、Nabila Kheder、Sobhi Gomha、Zeinab Muhammad
DOI:10.3390/molecules23112970
日期:——
4-diazabicyclo[2.2.2] octane) as an eco-friendly catalyst using the solvent-drop grinding method. The structure of the synthesized compounds was elucidated using elemental and spectroscopic analyses (IR, NMR, and Mass). The activity of these compounds against human hepatocellular carcinoma cell line (HepG2) was tested and the results showed that the pyrazoline 11f, which has a fluorinesubstituent, is the most
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity
作者:Huda K. Mahmoud、Thoraya A. Farghaly、Hanan G. Abdulwahab、Nadia T. Al-Qurashi、Mohamed R. Shaaban
DOI:10.1016/j.ejmech.2020.112752
日期:2020.12
Novel 2-indolinone thiazole hybrids were designed and synthesized as VEGFR-2 inhibitors based on sunitinib, an FDA-approved anticancer drug. The proposed structures of the prepared 2-indolinone thiazole hybrids were confirmed based on their spectral data and CHN analyses. The target compounds were screened in vitro for their anti-VEGFR-2 activity. All tested compounds exhibited a potent submicromolar